Merck
CN
  • Cardiolipin and phosphatidylethanolamine role in dibucaine interaction with the mitochondrial membrane.

Cardiolipin and phosphatidylethanolamine role in dibucaine interaction with the mitochondrial membrane.

Biochimica et biophysica acta. Biomembranes (2019-03-07)
S C Lopes, G Ivanova, B de Castro, P Gameiro
ABSTRACT

Mitochondrial membranes are pointed out as the site of cardiotoxic action of local anaesthetics. Its three main phospholipids components are phosphatidylcholine, phosphatidylethanolamine and cardiolipin. Cardiolipins, in eukaryotes, are only found in mitochondria and are essential for the maintenance of its integrity and dynamics. Fluorescence and nuclear magnetic resonance spectroscopy were used to study the interactions of a local anaesthetics, Dibucaine (DBC), with different mitochondrial membrane models constituted by combinations of its three main lipid components in which cardiolipin was a natural extract (CLmix). Both CLmix presence/absence and its percentage in the model membranes were evaluated. Fluorescence spectroscopy showed that DBC lowered the transition temperature of all membrane models understudy. DBC partition showed to be dependent of CLmix presence and phosphatidylethanolamine:CL ratio. Furthermore, the maximum emission wavelength (λmax) exhibited a notorious decreased with increasing phospholipid to DBC ratio, in all the membrane models containing CLmix. Nevertheless, it remained approximately the same in the membrane without CLmix. This indicates a differential membrane localization of the anaesthetics, dependent on the membrane models used. NMR results showed that DBC interaction and location in the membrane models is mainly influenced by CLmix presence, and DBC can significant alter lipid systems properties e.g. percentage and type of lipid phase present. Taken all together it was shown that DBC interaction and location are largely dependent on the membrane model system. Furthermore, DBC is able to produce significant changes in the lipidic systems which might help to explain its high toxicity.

MATERIALS
Product Number
Brand
Product Description

Avanti
16:0-06:0 NBD PE, Avanti Polar Lipids 810153P, powder
Avanti
16:0-06:0 NBD PE, Avanti Polar Lipids 810153C
Avanti
14:0-06:0 NBD PE, Avanti Polar Lipids 810151P, powder
Sigma-Aldrich
1,6-Diphenyl-1,3,5-hexatriene, 98%
Avanti
18:1-06:0 NBD PE, Avanti Polar Lipids 810155C
Avanti
14:0-12:0 NBD PE, Avanti Polar Lipids 810152P, powder
Avanti
18:1-12:0 NBD PE, Avanti Polar Lipids 810156P, powder
Avanti
16:0-12:0 NBD PE, Avanti Polar Lipids 810154P, powder
Sigma-Aldrich
DPH, ≥98% (HPLC)